found that butyrate supplementation activated AhR by increasing levels of the serotonin-derived metabolite 5-hydoxyindoleacetic acid (5-HIAA), suppressing rheumatoid arthritis in a Bregs-dependent manner (27). The gene discussed is AHR; the disease is rheumatoid arthritis.